logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong Stock Market Anomaly | Yangtze Life Science and Technology (00775.HK) Rises again by over 8% as the company showcases successful research in inhibiting tumor growth. The progress in vaccine research is expected to accelerate.

date
13/11/2025
According to the Wise Financial APP, Changjiang Life Technology (00775.HK) has risen by over 8% again, up 8.6% as of the time of publication, to HK$1.01, with a transaction amount of HK$23.28 million.
Latest
3 m ago
Ministry of Commerce: China and the West will further promote practical cooperation in the field of economy and trade.
4 m ago
Apple insiders respond to "unauthorized e-commerce platform cooperation ban notice"
5 m ago
Executive of the international oil development company, Idemitsu, stated that they will negotiate with the Japanese government and other partners regarding investments in the Sakhalin-1 oil project in Russia and discuss countermeasures against US sanctions on Russian oil companies.
5 m ago
Hong Kong Stock Market Moves | Kinshore Pharmaceuticals-B (02595.HK) Soared Over 8% in Late Trading, GFH375 Tablets Launched Phase III Clinical Trial for Metastatic Pancreatic Cancer.
5 m ago
Siemens CEO: Software will be an integral part of expected sales growth in the future.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.